middle.news
How CONNEQT’s $1.1M US Trial Contract Could Transform Cardiovascular Research
9:05am on Tuesday 28th of October, 2025 AEDT
•
Healthcare
Read Story
How CONNEQT’s $1.1M US Trial Contract Could Transform Cardiovascular Research
9:05am on Tuesday 28th of October, 2025 AEDT
Key Points
New Phase 2b clinical trial contract awarded by US biopharmaceutical company
Contract valued at approximately A$1.1 million over nine months
Deployment of 30 SphygmoCor XCEL and 60 Oscar 2 ABPM systems across 30 US sites
Services include equipment leasing, training, support, and data management
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Conneqt Health (ASX:CQT)
OPEN ARTICLE